Exogenus Therapeutics
Promoting development and commercialization of extracellular vesicles and other nanoparticles to tackle major healthcare challenges
Exogenus Therapeutics Chooses Lonza to Develop a GMP-Compliant Process to Manufacture Exo-101, its Lead Exosome-Based Candidate
Collaborative R&D
Unlock Innovation Through Collaborative R&D
Together, we can accelerate development, share expertise, and create the technologies of the future.
Pipeline
Explore the progress of our innovations, from discovery to clinical development
Our Team
Get to Know the Faces behind Exogenus Therapeutics
IP & Publications
Science First!
We believe that impactful discoveries should be open and transparent.
latest news
ABOUT EXOGENUS THERAPEUTICS Exogenus Therapeutics is a biotechnology company developing multifactorial, disease-modifying biologics for regenerative medicine. Our lead programme, Exo-101, is an extracellular-vesicle-enriched secretome in development for knee osteoarthritis. We are also exploring applications in cisplatin-induced hearing loss and other regenerative medicine indications. We combine scientific rigour, collaboration and responsible innovation to advance new therapies for patients. ABOUT THE ROLE We are looking for a Computational Biology & AI Solutions Specialist to help translate scientific and business needs into practical, responsible and scalable data and AI solutions. Working across R&D and business development, you will combine hands-on bioinformatics with the evaluation, implementation and adoption of AI-enabled tools for data analysis, knowledge management and competitive intelligence. This role is well suited to someone who enjoys working with complex biological datasets, applying emerging technologies to research challenges and collaborating across scientific disciplines. WHAT YOU WILL DO Computational Biology and Bioinformatics: Develop and maintain pipelines for transcriptomic, proteomic and other omics data analyses. Integrate and analyse datasets from multi-omics experiments. Establish appropriate standards for data quality, documentation, version control and reproducibility. Translate analytical results into clear outputs for multidisciplinary R&D teams. AI solutions and cross-functional enablement: Identify and implement AI-based tools and...
ABOUT EXOGENUS THERAPEUTICS Exogenus Therapeutics is a biotechnology company developing multifactorial, disease-modifying biologics for regenerative medicine. Our lead programme, Exo-101, is an extracellular-vesicle-enriched secretome in development for knee osteoarthritis. We are also exploring applications in cisplatin-induced hearing loss and other regenerative medicine indications. We combine scientific rigour, collaboration and responsible innovation to advance new therapies for patients. ABOUT THE ROLE We are looking for a Scientist with hands-on experience in cell-based bioassays to join our R&D team in Cantanhede. You will develop and run bioassays, contribute to experimental design and data interpretation, and support the introduction of robust workflows for research and quality-control applications. This role is well suited to someone who enjoys practical laboratory work, careful documentation and collaboration across scientific disciplines. WHAT YOU WILL DO Develop, optimise and implement cell-based and biomolecular in vitro bioassays and associated workflows. Plan and carry out experiments, analyse data and contribute to evidence-based technical decisions. Perform routine laboratory testing in accordance with approved protocols and quality requirements. Produce clear, accurate and traceable experimental records, reports and presentations. Contribute to assay transfer and quality-control activities in GMP-aligned or QMS environments. Support laboratory operations, including consumables planning, inventory and purchasing. Review relevant scientific literature...
Exogenus Therapeutics CEO, Joana Simões Correia, is a Finalist of the European Lifestars Awards 2026
Selected among Europe's leading life sciences executives, Exogenus Therapeutics CEO Joana Simões Correia has been named a finalist in the Women-Led Business of the Year category at the European Lifestars Awards 2026, organised by Informa Connect, the organisation behind BIO-Europe.Cantanhede, Portugal, 15 September 2026 – Exogenus Therapeutics, is proud to announce that its Chief Executive Officer, Joana Simões Correia, has been selected as a finalist in the Women-Led Business of the Year category at the European Lifestars Awards 2026. Organised by Informa Connect, the organisation behind BIO-Europe, one of the world's leading partnering events for the biotechnology and biopharmaceutical industries, the European Lifestars Awards celebrate exceptional leadership, innovation and value creation across the European life sciences ecosystem. The nomination recognises Joana Simões Correia's leadership in advancing Exogenus Therapeutics' mission to develop next-generation regenerative medicine solutions and in positioning the company as an emerging innovator within the European biotechnology landscape. Founded to unlock the therapeutic potential of exosome-based technologies, Exogenus Therapeutics has been working to advance innovative approaches in regenerative medicine, with the ambition of addressing significant unmet medical needs through cutting-edge science and translational innovation. "I am deeply honoured to be recognised among such an inspiring group of leaders from...
CENTRO2030-FSE+-0122970
CENTRO2030-FEDER-01680300
Co-financed by:

